Rare Tumors
metrics 2024
Innovating research for uncommon neoplasms.
Introduction
Rare Tumors, published by SAGE Publications Ltd, is a premier open-access journal dedicated to advancing the understanding and research of rare neoplasms. With the ISSN 2036-3605 and E-ISSN 2036-3613, this journal provides a vital platform for sharing innovative research findings and clinical insights since its inception in 2009. Situated in Italy, Rare Tumors has a converged publication timeline from 2010 to 2024 and aims to foster a supportive community for researchers and professionals in the oncology and histology fields. It has achieved a notable Q3 ranking in Oncology and Q4 in Histology as of 2023, reflecting its crucial role in bridging the knowledge gap in these specialized areas. Despite its relatively humble Scopus ranks, the journal's open-access model ensures that vital information reaches a broad audience, including those in academia, clinical practice, and beyond. It aspires to not only document rare tumor cases but also stimulate dialogue on their diagnosis, treatment, and management strategies, making it an indispensable resource for anyone dedicated to tackling the challenges posed by rare tumors.
Metrics 2024
Metrics History
Rank 2024
Scopus
IF (Web Of Science)
JCI (Web Of Science)
Quartile History
Similar Journals
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
Transforming insights into gynecological care.INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, published by Lippincott Williams & Wilkins, is a premier academic journal dedicated to the intricate field of gynecological pathology, serving a critical role in advancing the understanding of diseases related to women's reproductive health. Since its inception in 1982, this journal has established itself as a key resource for researchers, clinicians, and students, with a current impact factor that reflects its esteemed reputation; it is ranked in the Q2 category for both Obstetrics and Gynecology, as well as Pathology and Forensic Medicine, signifying its prominence in academic circles. The journal's scope encompasses a wide array of topics, including histopathological findings, diagnostic methodologies, and evolving therapeutic strategies, all pivotal to enhancing patient care. With a steadfast commitment to disseminating high-quality research until the projected year of 2024, the INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY is an essential read for those looking to stay abreast of the latest developments in this vital area of medical science.
Oxford Medical Case Reports
Unveiling the complexities of infectious diseases, one case at a time.Oxford Medical Case Reports is a pivotal open-access journal published by Oxford University Press that has been a significant contributor to the field of medical literature since its inception in 2014. With an ISSN of 2053-8855, this journal aims to disseminate case reports that enhance the understanding of infectious diseases, microbiology, and parasitology. While currently positioned in the Q4 quartile in these fields, the journal is dedicated to presenting unique clinical insights that not only foster professional development but also support the educational needs of students and emerging researchers. Its open-access model ensures that vital research is accessible to a global audience, facilitating knowledge sharing and collaboration across disciplines. With an ambition to improve its rankings and a vision to expand its impact on medical practice, Oxford Medical Case Reports stands as a valuable resource for healthcare professionals striving to stay informed about the latest case-based advancements in their fields.
Case Reports in Nephrology and Dialysis
Transforming nephrology with every case report.Case Reports in Nephrology and Dialysis, published by KARGER, is a vital peer-reviewed journal dedicated to the dissemination of case reports and innovative findings in the fields of nephrology and dialysis. Since its inception in 2015, this Open Access journal has aimed to foster knowledge exchange and improve patient outcomes through comprehensive case studies, clinical insights, and recent advancements in renal healthcare. Based in Switzerland, the journal is poised to serve a global audience, accommodating research that spans diverse geographical and clinical contexts. Currently ranked in the Q3 category for nephrology in 2023, it underscores its burgeoning influence in the medical literature, despite its relatively nascent presence. As a valuable resource for researchers, healthcare professionals, and students, it provides a platform for sharing unique cases that enrich the understanding of complex renal issues and challenges faced in dialysis. With an emphasis on high-quality, accessible research, Case Reports in Nephrology and Dialysis is committed to advancing nephrology and dialysis practices through collaboration and knowledge sharing.
Gastrointestinal Tumors
Bridging Knowledge Gaps in Tumor ResearchGastrointestinal Tumors is a reputable, peer-reviewed journal dedicated to advancing knowledge in the field of gastrointestinal oncology. Published by KARGER, this journal has been a pivotal platform since its transition to Open Access in 2014, ensuring that research findings are accessible to a global audience of researchers, clinicians, and students engaged in this vital area of study. With an emphasis on innovative research, clinical studies, and comprehensive reviews, Gastrointestinal Tumors aims to bridge gaps in knowledge and foster discussions that will inform and enhance clinical practices. The journal's commitment to excellence reflects the rising importance of gastrointestinal health in medical research, making it an essential resource for anyone seeking to stay at the forefront of this rapidly evolving field. Based in Basel, Switzerland, it is positioned within a strong academic community, and continues to influence the landscape of gastrointestinal cancer research.
Molecular and Clinical Oncology
Transforming insights into impactful oncology practices.Molecular and Clinical Oncology is a dynamic journal published by SPANDIDOS PUBL LTD, aimed at advancing the understanding of cancer biology and treatment modalities. With an ISSN of 2049-9450 and an E-ISSN of 2049-9469, the journal serves as a critical platform for researchers and clinicians dedicated to uncovering novel insights in molecular oncology and enhancing clinical practices. As a testament to its growing influence, the journal has achieved a Q3 ranking in Oncology and a Q4 ranking in Cancer Research for the year 2023, reflecting its commitment to publishing high-quality research. Although currently not an Open Access publication, the journal offers crucial subscription options, ensuring comprehensive access to groundbreaking studies and innovations in the field. With converged years spanning 2018 to 2024, the journal is set to continue enriching the academic community with its valuable contributions, ultimately empowering researchers, professionals, and students engaged in the fight against cancer.
Archive of Clinical Cases
Empowering healthcare professionals with evidence-based findings.Archive of Clinical Cases is a premier journal dedicated to the dissemination of high-quality research in the field of clinical medicine and case studies. Published by GRIGORE T POPA UNIV MEDICINE AND PHARMACY IASI, this journal aims to bridge the gap between clinical practice and research, providing a platform for healthcare professionals, researchers, and students to share their findings and insights. With an emphasis on advancing medical knowledge through case reports, the journal plays a crucial role in enhancing evidence-based practices in clinical settings. Though the journal operates under an open-access model, its commitment to rigorous peer review ensures the integrity and quality of all published work. It invites contributions that contribute to the understanding of complex clinical scenarios, making it an invaluable resource for academics and practitioners alike. For those looking to expand their knowledge and stay abreast of the latest developments in clinical case reporting, the Archive of Clinical Cases is an indispensable addition to their academic journey.
American Journal of Case Reports
Transforming clinical practice through shared experiences.The American Journal of Case Reports, published by INT SCIENTIFIC INFORMATION, INC since 2008, serves as a crucial platform in the field of Medicine, specifically focusing on clinical cases that enhance medical knowledge and expertise. With an impact factor that reflects its quality and relevance, this journal ranks in the Q3 quartile of its category and holds a notable position at Rank #259 out of 636 in the Scopus Medicine rankings, placing it within the 59th percentile among its peers. Intended for researchers, healthcare professionals, and students, the American Journal of Case Reports advocates for the sharing of distinctive case studies, thus fostering a deeper understanding of clinical practice and patient care across a spectrum of medical disciplines. As an open access journal, it ensures widespread dissemination of vital case reports, opening avenues for global collaboration and knowledge exchange, ultimately enhancing evidence-based practice in medicine.
AME Case Reports
Bridging Gaps in Medicine Through Collaborative ReportingAME Case Reports, published by AME PUBLISHING COMPANY, is a peer-reviewed open-access journal dedicated to the dissemination of high-quality clinical case reports across various medical disciplines. With an expanding focus on innovative medical practices and clinical experiences, this journal serves as an essential platform for healthcare professionals, researchers, and medical students to share significant findings and insights that contribute to evidence-based practices. Although specific metrics such as impact factors and H-index are not currently available, the journal's commitment to academic rigor and accessibility fosters an environment for scholarly exchange and professional development. The publication facilitates immediate access to important case studies that may inform clinical decisions and improve patient care. In an era where sharing specialized knowledge is paramount, AME Case Reports stands as a vital resource for those involved in the medical community worldwide.
Case Reports in Gastrointestinal Medicine
Elevating practice with essential case report findings.Case Reports in Gastrointestinal Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of significant findings in the field of gastrointestinal medicine. Established in 2011, this journal champions the accessibility of scholarly work, allowing researchers, professionals, and students to explore vital case studies that enhance clinical understanding and patient care across various gastrointestinal conditions. With an emphasis on innovative practices and advances in treatment, the journal serves as an invaluable resource for those committed to furthering their knowledge and improving outcomes in gastrointestinal health. By promoting the robust sharing of case reports and clinical insights, Case Reports in Gastrointestinal Medicine not only contributes to the academic community but also supports practitioners in their quest for evidence-based practice.
Chinese Clinical Oncology
Transforming the landscape of cancer treatment and research.Chinese Clinical Oncology is a distinguished journal dedicated to advancing the field of oncology and clinical research, published by AME Publishing Company. Since its inception in 2012, this journal has established its significance within the academic community, boasting an impactful presence as evidenced by its 2023 Scopus rankings, where it is positioned in the 47th percentile in the field of oncology. This open access journal features a diverse range of research, reviews, and clinical studies that aim to bridge the gap between experimental and clinical oncology, making it an invaluable resource for researchers, medical professionals, and students alike. The journal is based in Hong Kong and is committed to publishing studies that contribute to the understanding and treatment of cancer, with a strong focus on innovative methodologies and emerging therapies. With a current categorization of Q2 in Medicine and Q3 in Oncology, Chinese Clinical Oncology offers a robust platform for scholarly communication and is pivotal for those involved in cancer research and treatment.